These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. L-Dopa in the treatment of parkinsonism. Calne DB Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292 [No Abstract] [Full Text] [Related]
25. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related]
26. Failures of L-dopa. Paulson GW Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406 [No Abstract] [Full Text] [Related]
27. [Side effects occurring in the course of treatment of parkinsonism with L-dopa]. Kuran W Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001 [No Abstract] [Full Text] [Related]
28. Modification of Parkinsonism--chronic treatment with L-dopa. Cotzias GC; Papavasiliou PS; Gellene R N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641 [No Abstract] [Full Text] [Related]
29. Deanol in the treatment of levodopa-induced dyskinesias. Klawans HL; Topel JL; Bergen D Neurology; 1975 Mar; 25(3):290-3. PubMed ID: 1167639 [TBL] [Abstract][Full Text] [Related]
30. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342 [No Abstract] [Full Text] [Related]
31. [Results of treatment of Parkinsonism with L-dopa]. De Divitiis E; D'Andrea F; Signorelli CD Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563 [No Abstract] [Full Text] [Related]
32. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation]. Antonini F; Baroni A; Roveyaz L Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560 [No Abstract] [Full Text] [Related]
33. L-dopa therapy in Parkinson's disease. Lipman IJ Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138 [No Abstract] [Full Text] [Related]
37. [Clinical study of L-dopa in Parkinson's disease]. Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350 [No Abstract] [Full Text] [Related]
38. Potentiation of the L-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors. Ericsson AD J Neurol Sci; 1971 Oct; 14(2):193-7. PubMed ID: 5112212 [No Abstract] [Full Text] [Related]
39. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). Gutmann L; Martin JD; Gutrecht JA W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660 [No Abstract] [Full Text] [Related]
40. [L-dopa induced psychosis-dyskinesia complex]. Ikeda H; Baba O; Ishino H No To Shinkei; 1972 Mar; 14(3):275-80. PubMed ID: 5067044 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]